ENDUR ACIN Wax Matrix Niacin Research STUDIES

Highlights ENDUR-ACIN® decreases LDL-cholesterol by 27% and increases HDL-cholesterol by 17%, on average Effective amounts of ENDUR-ACIN® range from 1,500-2,000 mg/day ENDUR-ACIN® therapeutic benefits for hypercholesterolemia and/or low HDL-cholesterol. Summary...

Highlights ENDUR-ACIN® improves blood cholesterol in hyperlipidemic patients with coronary artery disease 13% reduction in total cholesterol, on average 31% increase in HDL cholesterol, on average Well tolerated with only...

Highlights ENDUR-ACIN® improves blood lipids in patients with Types IIa and IIb hyperlipoproteinemias Improvements in lipid transport proteins apo-A1 and apo-B also seen Treatment reported to be well tolerated by...

Highlights ENDUR-ACIN® significantly improves blood lipids in patients with hyperlipidemia Effective dosage is 1,500 to 2,000 mg/day Significant improvements in blood lipids and transfer proteins reported Low 5% dropout rate...

Highlights ENDUR-ACIN® therapy improves lipid profiles in men with dyslipidemia comparable to lovastatin therapy. Summary This randomized, double-blind, controlled trial, completed by University of Minnesota researcher Joseph Keenan, M.D., in...